These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 26953090

  • 1. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.
    Pozzoli M, Rogueda P, Zhu B, Smith T, Young PM, Traini D, Sonvico F.
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1660-8. PubMed ID: 26953090
    [Abstract] [Full Text] [Related]

  • 2. Limitations of high dose carrier based formulations.
    Yeung S, Traini D, Tweedie A, Lewis D, Church T, Young PM.
    Int J Pharm; 2018 Jun 10; 544(1):141-152. PubMed ID: 29649519
    [Abstract] [Full Text] [Related]

  • 3. Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler.
    Yeung S, Traini D, Tweedie A, Lewis D, Church T, Young PM.
    AAPS PharmSciTech; 2019 Jan 28; 20(3):94. PubMed ID: 30690674
    [Abstract] [Full Text] [Related]

  • 4. Effect of Dosing Cup Size on the Aerosol Performance of High-Dose Carrier-Based Formulations in a Novel Dry Powder Inhaler.
    Yeung S, Traini D, Tweedie A, Lewis D, Church T, Young PM.
    J Pharm Sci; 2019 Feb 28; 108(2):949-959. PubMed ID: 30312722
    [Abstract] [Full Text] [Related]

  • 5. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
    Jetmalani K, Young PM, Smith T, Stewart P, Traini D.
    Drug Dev Ind Pharm; 2012 Dec 28; 38(12):1504-11. PubMed ID: 22335558
    [Abstract] [Full Text] [Related]

  • 6. Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation.
    Xu LM, Zhang QX, Zhou Y, Zhao H, Wang JX, Chen JF.
    Int J Pharm; 2012 Oct 15; 436(1-2):1-9. PubMed ID: 22732674
    [Abstract] [Full Text] [Related]

  • 7. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC, Migounov VA.
    Respir Care; 2003 Nov 15; 48(11):1025-32. PubMed ID: 14585114
    [Abstract] [Full Text] [Related]

  • 8. Beclomethasone dipropionate nasal aerosol with an integrated dose counter: functionality and performance.
    Meltzer EO, Korenblat PE, Lanier BQ, Kelley L, Tantry SK.
    Allergy Asthma Proc; 2013 Nov 15; 34(6):534-41. PubMed ID: 24169062
    [Abstract] [Full Text] [Related]

  • 9. Opportunity and challenges of nasal powders: Drug formulation and delivery.
    Tiozzo Fasiolo L, Manniello MD, Tratta E, Buttini F, Rossi A, Sonvico F, Bortolotti F, Russo P, Colombo G.
    Eur J Pharm Sci; 2018 Feb 15; 113():2-17. PubMed ID: 28942007
    [Abstract] [Full Text] [Related]

  • 10. Patient satisfaction with beclomethasone dipropionate nasal aerosol device with integrated dose counter during daily use.
    Gross GN, Settipane RA, Ford LB, Kelley L, Tantry SK.
    Allergy Asthma Proc; 2013 Feb 15; 34(6):527-33. PubMed ID: 24169061
    [Abstract] [Full Text] [Related]

  • 11. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F, Scuri M, Vezzoli S, Francisco C, Petruzzelli S.
    Pulm Pharmacol Ther; 2015 Feb 15; 30():121-7. PubMed ID: 25088067
    [Abstract] [Full Text] [Related]

  • 12. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, Pasquali I.
    J Aerosol Med Pulm Drug Deliv; 2016 Apr 15; 29(2):167-78. PubMed ID: 26355743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dry powder inhaler device influence on carrier particle performance.
    Donovan MJ, Kim SH, Raman V, Smyth HD.
    J Pharm Sci; 2012 Mar 15; 101(3):1097-107. PubMed ID: 22095397
    [Abstract] [Full Text] [Related]

  • 18. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA, Young PM, Buttini F, Church T, Colombo P, Forbes B, Haghi M, Johnson R, O'Shea H, Salama R, Traini D.
    Eur J Pharm Biopharm; 2014 Jan 15; 86(1):31-7. PubMed ID: 23523547
    [Abstract] [Full Text] [Related]

  • 19. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
    Pozzoli M, Traini D, Young PM, Sukkar MB, Sonvico F.
    Drug Dev Ind Pharm; 2017 Sep 15; 43(9):1510-1518. PubMed ID: 28425305
    [Abstract] [Full Text] [Related]

  • 20. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F, Miozzi M, Balducci AG, Royall PG, Brambilla G, Colombo P, Bettini R, Forbes B.
    Int J Pharm; 2014 Apr 25; 465(1-2):42-51. PubMed ID: 24491530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.